EP 1539807 A4 20060906 - THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS ENCODING SAME, AND METHODS OF USE
Title (en)
THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS ENCODING SAME, AND METHODS OF USE
Title (de)
THERAPEUTISCHE POLYPEPTIDE, FÜR DIESE KODIERENDE NUKLEINSÄUREN UND ANWENDUNGSVERFAHREN
Title (fr)
POLYPEPTIDES THERAPEUTIQUES, ACIDES NUCLEIQUES CODANT CES POLYPEPTIDES ET LEURS PROCEDES D'UTILISATION
Publication
Application
Priority
- US 0324931 W 20030807
- US 40159702 P 20020807
- US 40220902 P 20020809
- US 40220502 P 20020809
- US 40354802 P 20020813
- US 40351702 P 20020813
- US 40369602 P 20020815
- US 40631802 P 20020826
- US 40620202 P 20020827
- US 23639202 A 20020906
- US 24294302 A 20020913
- US 42313802 P 20021101
- US 63514903 A 20030806
Abstract (en)
[origin: WO2004015079A2] Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide. Vectors, host cells, antibodies and recombinant methods for producing the polypeptides and polynucleotides, as well as methods for using same are also included. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
IPC 1-7
IPC 8 full level
A61K 38/04 (2006.01); C07H 21/02 (2006.01); C07K 14/00 (2006.01); C07K 14/47 (2006.01); C12N 15/00 (2006.01)
IPC 8 main group level
C12N (2006.01)
CPC (source: EP)
A61P 3/04 (2017.12); A61P 3/06 (2017.12); A61P 3/10 (2017.12); A61P 17/02 (2017.12); A61P 25/00 (2017.12); A61P 25/16 (2017.12); A61P 25/28 (2017.12); A61P 35/00 (2017.12); C07K 14/47 (2013.01)
Citation (search report)
- [X] WO 0164885 A1 20010907 - AMGEN INC [US], et al
- [X] WO 02054940 A2 20020718 - UNIV NEW JERSEY MED [US], et al
- [PX] US 2003134790 A1 20030717 - LANGENFELD JOHN [US]
- [X] MILLET CAROLINE ET AL: "The human chordin gene encodes several differentially expressed spliced variants with distinct BMP opposing activities", MECHANISMS OF DEVELOPMENT, vol. 106, no. 1-2, August 2001 (2001-08-01), pages 85 - 96, XP002371537, ISSN: 0925-4773
- [X] DATABASE Geneseq [online] 15 July 2002 (2002-07-15), "Human PRO243 polypeptide.", XP002379180, retrieved from EBI accession no. GSP:AAU86132 Database accession no. AAU86132 & DATABASE Geneseq [online] 15 January 2002 (2002-01-15), "Human chordin protein.", retrieved from EBI accession no. GSP:AAE12889 Database accession no. AAE12889 & DATABASE Geneseq [online] 21 October 2002 (2002-10-21), "Human chordin (CHRD) protein.", retrieved from EBI accession no. GSP:ABG31265 Database accession no. ABG31265 & DATABASE UniProt [online] 1 March 2001 (2001-03-01), "Chordin precursor.", retrieved from EBI accession no. UNIPROT:CHRD_HUMAN Database accession no. CHRD_HUMAN & DATABASE Geneseq [online] 12 February 2004 (2004-02-12), "Human chordin protein.", retrieved from EBI accession no. GSP:ABW01852 Database accession no. ABW01852 & WO 0153486 A1 20010726 - GENENTECH INC [US], et al
- See references of WO 2004015079A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2004015079 A2 20040219; WO 2004015079 A3 20040902; AU 2003259704 A1 20040225; CA 2495563 A1 20040219; EP 1539807 A2 20050615; EP 1539807 A4 20060906; JP 2006515753 A 20060608
DOCDB simple family (application)
US 0324931 W 20030807; AU 2003259704 A 20030807; CA 2495563 A 20030807; EP 03785086 A 20030807; JP 2005506604 A 20030807